These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7477189)

  • 61. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 63. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.
    Brabant SM; Eyraud D; Bertrand M; Coriat P
    Anesth Analg; 1999 Oct; 89(4):887-8. PubMed ID: 10512259
    [No Abstract]   [Full Text] [Related]  

  • 65. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.
    Lacourcière Y; Brunner H; Irwin R; Karlberg BE; Ramsay LE; Snavely DB; Dobbins TW; Faison EP; Nelson EB
    J Hypertens; 1994 Dec; 12(12):1387-93. PubMed ID: 7706699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cross-sensitivity between angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonist].
    Touraud JP; Collet E; Louguet C; Sgro C; Dalac S; Dutronc Y; Lambert D
    Ann Dermatol Venereol; 2002; 129(8-9):1033-6. PubMed ID: 12442102
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
    Goa KL; Wagstaff AJ
    Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

  • 70. [Nonpeptide angiotensin II receptor antagonists].
    Nishikawa K
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1873-80. PubMed ID: 8210431
    [No Abstract]   [Full Text] [Related]  

  • 71. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiotensin receptor blockers in essential hypertension.
    Brown MJ
    Lancet; 1993 Dec; 342(8884):1374-5. PubMed ID: 7901674
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
    De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
    Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Therapy of hypertension. A new rapidly effective AT1 blocker].
    MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136675
    [No Abstract]   [Full Text] [Related]  

  • 75. Anaemia in dialysis patients as a side-effect of sartanes.
    Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
    Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412
    [No Abstract]   [Full Text] [Related]  

  • 76. The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man.
    Belz GG; Breithaupt-Grögler K; Butzer R; Fuchs W; Hausdorf C; Mang C
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):336-41. PubMed ID: 11967820
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group.
    Crozier I; Ikram H; Awan N; Cleland J; Stephen N; Dickstein K; Frey M; Young J; Klinger G; Makris L
    Circulation; 1995 Feb; 91(3):691-7. PubMed ID: 7828295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
    Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.